RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ScreeningHang in there Toinv, !!! My thinking is Don has a very short window (4 months or less for things on both the science and business side, financing of both trials, partnering or something else to occur before the walls start close in on him. Oristar is invested at $1.08 and I am sure hepalink is invested higher that $1.08 over the past 10 years , as well as Eastern capital. Those 3 insider probably know the science is solid and will take a few years to demonstate a succesful trial and then either a buyout or a self go drug developer with the help of Eversana which is huge boost in my confidence for RVX to be 100% successful in a few years. If we can get some wind in our SP shares with good early COVID trial results and with the help of a professional international PR team to get international media exposure will get a ton of new investers and maybe institutional investors as well. Lets see what early 2022 brings us. !!!